Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1409 publications
PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 US$ 10,995.00

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most ... subcutaneous reformulation of Herceptin will limit this impact. Development of new HER2-targeting therapies is slow, with only one agent, Puma Biotechnology’s ...

Sep, 2014 323 pages
University of Maryland Greenebaum Cancer Center – Developmental Therapeutics Review – Q4 2010 US$ 500.00 US$ 450.00

... to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps. - Evaluate University of Maryland Greenebaum Cancer Center’s position with total access to a detailed intelligence on its therapeutic products development. - Assess the growth ...

Nov, 2010 40 pages
Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies US$ 3,900.00

... is vital for ensuring optimal performance levels of Medical Affairs teams. In Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and ... and timely EdgeMap and Need-Gap analysis of oncologists' perceptions of Medical Affairs teams highlighting good and bad performance and identifying ...

Dec, 2014
Physician Views: Reaction to Bristol-Myers Squibb's Opdivo data in non-small-cell lung cancer US$ 645.00

... proportion attributed to lung cancer. Little surprise then, perhaps, that Bristol-Myers Squibb's share price jumped some 9 percent last week ... patients, were unveiled (ViewPoints: Investors respond in kind to impressive data for Bristol-Myers Squibb NSCLC immunotherapy). Checkmate-063 recruited 117 patients, ...

Nov, 2014
Global Oncology Biosimilars Market 2014-2018 US$ 2,500.00

... after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original ... generated from the sales biosimilars used in cancer treatment. TechNavio's report, Global Oncology Biosimilars Market 2014-2018, has been prepared based ...

Nov, 2014 71 pages
2014-2018 World Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US US$ 34,500.00

... , and can be custom-tailored to your specific information needs and budget. '2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, ... test and country. Five-year test volume and sales forecasts for major tumor markers by country and market segment, including: Hospitals ...

Nov, 2014 1200 pages
2014-2018 US Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 9,800.00

... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ... strategies. Potential market entry barriers and risks. Cancer Diagnostic Tests—Over 200 current and emerging assays including: ACTH, AFP ...

Nov, 2014 620 pages
2014-2018 UK Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ... strategies. Potential market entry barriers and risks. Cancer Diagnostic Tests—Over 200 current and emerging assays including: ACTH, AFP ...

Nov, 2014 565 pages
2014-2018 Spanish Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; ...

Nov, 2014 565 pages
2014-2018 Japanese Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 7,600.00

... cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; ...

Nov, 2014 590 pages
2014-2018 Italian Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; ...

Nov, 2014 570 pages
2014-2018 German Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; ...

Nov, 2014 585 pages
2014-2018 French Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; ...

Nov, 2014 585 pages
2014-2018 European Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK US$ 19,700.00

... trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...

Nov, 2014 820 pages
2014-2018 World Tumor Marker Diagnostic Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

This new report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product ...

Nov, 2014 80 pages
2014-2018 World Tumor Marker Testing Market Overview: Test Volume and Sales Forecasts by Country US$ 2,450.00

... a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables

Nov, 2014 11 pages
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight US$ 2,400.00

... market approval by the FDA in 2013 for the treatment of mantel cell lymphoma. In 2014, this drug also got the FDA’s approval for chronic ... size of Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview ...

Nov, 2014 573 pages
Liposarcoma - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

Summary Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H2 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative analysis at various stages, therapeutics ...

Nov, 2014 78 pages
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies US$ 4,995.00 US$ 4,496.00

... intelligence provider, has released its latest research, 'Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive ... failure rates and pipeline analysis, and analysis of deals relevant to Colorectal Cancer (CRC). The market in the APAC region was worth an ...

Oct, 2014 98 pages
Competitor Analysis: Cancer Peptides US$ 500.00

Competitor Analysis: Cancer Peptides The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the ...

Nov, 2014 99 pages
Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation US$ 6,995.00

Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in NSCLC Pipeline The NSCLC ... strategic implications for a wide array of market participants, both large and small. Despite a high attrition rate in NSCLC, first-in-class therapies that ...

Oct, 2014 93 pages
Global Prostate Cancer Drugs Market 2014-2018 US$ 2,500.00

... younger than 40 years of age. TechNavio's analysts forecast the Global Prostate Cancer Drugs market to grow at a CAGR of 10.45 percent over the period 2013- ... The report also includes a discussion of the key vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Abbvie Astra ...

Nov, 2014 71 pages
2014-2018 World Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US US$ 34,500.00

... market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; ... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ...

Nov, 2014 1200 pages
2014-2018 World Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Sales Forecasts, and Strategic Profiles of Leading Suppliers US$ 7,500.00

This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer testing laboratories, ...

Nov, 2014 510 pages
2014-2018 US Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 9,800.00

... $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400. “2014 Opportunities in the US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 620 pages
2014-2018 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... $6,700. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the UK Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 565 pages
2014-2018 Spanish Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... 700. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Spanish Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 565 pages
2014-2018 Japanese Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 7,600.00

... . DataPack (test volumes, sales forecasts, supplier shares) $4,300. “2014 Opportunities in the Japanese Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 590 pages
2014-2018 Italian Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... 700. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Italian Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 570 pages
2014-2018 German Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... 700. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the German Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 585 pages
2014-2018 French Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies US$ 6,700.00

... 700. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the French Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

Nov, 2014 585 pages
2014-2018 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK US$ 19,700.00

... of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. ... Recommendations Specific new product development opportunities with potentially significant market appeal during the next five years. Design criteria for ...

Nov, 2014 820 pages
2014-2018 World Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

This new report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product ...

Nov, 2014 80 pages
2014-2018 Analysis of Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers US$ 3,500.00

... Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers ...

Nov, 2014 286 pages
AntiCancer, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AntiCancer, Inc.’s pipeline products ... areas of focus Identify new drug targets and therapeutic classes in the AntiCancer, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce ...

Oct, 2014 24 pages
Global Breast Cancer Vaccine Clinical Trial Insight US$ 1,200.00

... Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: Global Breast Cancer Vaccine Market Overview Global Breast Cancer Vaccine Clinical Pipeline by ... are used to prevent cancer from developing in healthy people. With the approval of the prostate cancer vaccine, Provenge by Dendreon, the field of ...

Oct, 2014 134 pages
Papillary Thyroid Cancer - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

... Review, H2 2014’, provides an overview of the Papillary Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Oct, 2014 75 pages
Metastatic Uveal Melanoma - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

... Review, H2 2014’, provides an overview of the Metastatic Uveal Melanoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Oct, 2014 58 pages
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

... , H2 2014’, provides an overview of the Hormone-Sensitive Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Oct, 2014 36 pages
Global and Chinese Cervical Plates Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Plates industry covering all important parameters ...

Oct, 2014 150 pages
Global and Chinese Cervical Disc Prostheses Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and ... . Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Disc Prostheses industry covering all important parameters.

Oct, 2014 150 pages
Global and Chinese Cervical Dilators Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Dilators industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Collars Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Collars industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Brushes Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Brushes industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Brush Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Brush industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Biopsy Forceps Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and ... . Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Biopsy Forceps industry covering all important parameters.

Oct, 2014 150 pages
Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 US$ 3,495.00

... Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023”. ... Medicines Agency (EMA) in 2008, for use in locally-advanced or metastatic breast cancer, in combination with Xeloda (capecitabine). In 2010, the FDA and ...

Sep, 2014 55 pages
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... the high treatment rates in the neoadjuvant and adjuvant settings using HER2-targeted therapies in all stages, have helped drive the sales ... afford to reimburse the latest expensive drugs. Scope An overview of HER2-Positive Breast Cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology ...

Sep, 2014 165 pages
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Analysis of unmet needs within the ... sizing, forecasts and quantified growth opportunities in the Japan HER2-Positive Breast Cancer market through 2018. Quantify candidate patient populations ...

Sep, 2014 158 pages
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Analysis of unmet needs within the ... sizing, forecasts and quantified growth opportunities in the China HER2-Positive Breast Cancer market through 2018. Quantify candidate patient populations ...

Sep, 2014 154 pages
1 2 3 4 5 >
Skip to top